Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biogen Inc (BIIB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 60,437,372
  • Shares Outstanding, K 213,620
  • Annual Sales, $ 11,449 M
  • Annual Income, $ 3,703 M
  • 36-Month Beta 0.78
  • Price/Sales 5.25
  • Price/Cash Flow 11.90
  • Price/Book 5.24

Price Performance

See More
Period Period Low Period High Performance
1-Month
268.91 +5.21%
on 06/29/17
285.84 -1.02%
on 07/19/17
+4.32 (+1.55%)
since 06/21/17
3-Month
244.28 +15.82%
on 05/31/17
291.90 -3.08%
on 04/25/17
+9.98 (+3.66%)
since 04/21/17
52-Week
244.28 +15.82%
on 05/31/17
307.33 -7.94%
on 08/02/16
+22.75 (+8.75%)
since 07/21/16

Most Recent Stories

More News
Can Biogen (BIIB) Keep the Earnings Streak Alive in Q2?

At Biogen's (BIIB) Q2 call, investor focus will remain on Tecfidera's scrip trends, pipeline progress and acquisition plans. All eyes will also be on Spinraza's performance in Q2.

LLY : 84.66 (-0.11%)
ABBV : 74.63 (+0.84%)
PFE : 33.48 (-0.18%)
BIIB : 282.92 (+0.53%)
Biotech Stock Roundup: Vertex Boosted by CF Data, FDA Nod for Gilead, Puma Drugs

Vertex (VRTX) got a significant boost with positive data from its cystic fibrosis (CF) pipeline while quite a few companies provided regulatory updates.

SRPT : 43.41 (+6.06%)
PBYI : 94.30 (-0.47%)
VRTX : 163.17 (+2.41%)
GILD : 73.76 (+0.46%)
AMGN : 180.21 (+0.50%)
ALXN : 131.79 (+1.53%)
BIIB : 282.92 (+0.53%)
Featured Company News - Ionis Receives $10 Million Payment from Biogen

LONDON, UK / ACCESSWIRE / July 19, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), following which we have...

IONS : 56.39 (+0.95%)
BIIB : 282.92 (+0.53%)
Watch for Biogen Inc to Potentially Pullback After Gaining 1.17% Yesterday

Biogen Inc (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $279.51 to a high of $284.30. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $281.34...

BIIB : 282.92 (+0.53%)
Biogen to Present Data at Alzheimer's Association International Conference(R) 2017 (AAIC(R))

Biogen (NASDAQ: BIIB) will present data from its Alzheimer's disease programs at the Alzheimer's Association International Conference(R) 2017 (AAIC(R)) in London, July 16 - 20, 2017....

BIIB : 282.92 (+0.53%)
Top Stock Reports for Boeing, AbbVie & U.S. Bancorp

Top Stock Reports for Boeing, AbbVie & U.S. Bancorp

NFLX : 188.54 (+2.69%)
USB : 52.12 (-0.69%)
STZ : 198.52 (+0.20%)
ABBV : 74.63 (+0.84%)
BIIB : 282.92 (+0.53%)
BA : 212.14 (+0.88%)
SmarTrend Watching for Potential Rebound in Shares of Biogen Inc After 1.25% Loss

Biogen Inc (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $269.50 to a high of $274.10. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $270.31...

BIIB : 282.92 (+0.53%)
Watch for Biogen Inc to Potentially Rebound After Falling 1.25% Yesterday

Biogen Inc (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $269.50 to a high of $274.10. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $270.31...

BIIB : 282.92 (+0.53%)
Biogen Appoints Amy Chevalier Efantis Vice President of Government Affairs

Biogen (NASDAQ: BIIB) announced today the appointment of Amy Chevalier Efantis as Vice President of Government Affairs, effective July 17.

BIIB : 282.92 (+0.53%)
Biotech Stock Roundup: Cara Plunges on Study Data, Regulatory Updates & More

Key highlights in the biotech sector include mixed data from Cara (CARA) and regulatory updates from companies like BioMarin.

CARA : 15.35 (-0.71%)
BMRN : 89.28 (+1.76%)
ACOR : 20.65 (-1.20%)
ALKS : 57.73 (+0.35%)
AMGN : 180.21 (+0.50%)
BIIB : 282.92 (+0.53%)
OPXA : 0.90 (-1.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

See More

Business Summary

Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia,...

See More

Support & Resistance

2nd Resistance Point 284.96
1st Resistance Point 283.94
Last Price 282.92
1st Support Level 280.96
2nd Support Level 279.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.